Specify a stock or a cryptocurrency in the search bar to get a summary
Odonate Therapeutics
ODTCOdonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York. Address: 3 East 28th Street, New York, NY, United States, 10016
Analytics
WallStreet Target Price
4 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ODTC
Dividend Analytics ODTC
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ODTC
Stock Valuation ODTC
Financials ODTC
Results | 2019 | Dynamics |